| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.86B | 64.51B | 61.61B | 60.12B | 57.05B | 53.75B |
| Gross Profit | 20.58B | 20.64B | 20.31B | 19.61B | 18.52B | 17.31B |
| EBITDA | 7.04B | 8.29B | 6.32B | 5.84B | 6.01B | 5.52B |
| Net Income | 1.17B | 1.14B | 1.36B | 1.54B | 1.82B | 431.00M |
Balance Sheet | ||||||
| Total Assets | 52.10B | 52.17B | 51.44B | 49.77B | 48.96B | 47.08B |
| Cash, Cash Equivalents and Short-Term Investments | 1.24B | 1.49B | 2.70B | 2.92B | 2.82B | 3.86B |
| Total Debt | 20.04B | 19.58B | 22.21B | 21.30B | 20.65B | 19.50B |
| Total Liabilities | 39.85B | 39.56B | 38.30B | 36.31B | 35.78B | 33.95B |
| Stockholders Equity | 4.88B | 5.28B | 6.24B | 6.67B | 6.84B | 6.96B |
Cash Flow | ||||||
| Free Cash Flow | 3.95B | 3.23B | 3.10B | 3.01B | 2.60B | 3.21B |
| Operating Cash Flow | 6.18B | 5.29B | 5.11B | 4.95B | 4.07B | 4.26B |
| Investing Cash Flow | -2.42B | -2.15B | -2.31B | -1.68B | -2.55B | -289.00M |
| Financing Cash Flow | -3.83B | -3.34B | -3.22B | -3.13B | -2.19B | -3.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | C$18.69B | 20.48 | 14.38% | 1.50% | 3.52% | 5.04% | |
67 Neutral | C$3.49B | 20.25 | 36.56% | 4.95% | -13.45% | 465.50% | |
65 Neutral | C$46.37B | 31.96 | 94.71% | 0.20% | 13.14% | 13.84% | |
64 Neutral | C$70.52B | 31.17 | 24.88% | 1.52% | 4.36% | 28.73% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | C$35.91B | 80.13 | 21.94% | 1.23% | 4.36% | -0.82% | |
56 Neutral | C$10.57B | -6.61 | 2.98% | 1.78% | 2.35% | -76.67% |